Cargando…
Control of Tumor Progression by Angiocrine Factors
SIMPLE SUMMARY: The growth of a solid malignant tumor mass depends on the formation of new blood vessels by endothelial cells. However, endothelial cells do not only provide conduits for blood transportation, but also express numerous factors which promote the aggressiveness of cancer cells, influen...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198241/ https://www.ncbi.nlm.nih.gov/pubmed/34073394 http://dx.doi.org/10.3390/cancers13112610 |
_version_ | 1783707091075072000 |
---|---|
author | Alsina-Sanchis, Elisenda Mülfarth, Ronja Fischer, Andreas |
author_facet | Alsina-Sanchis, Elisenda Mülfarth, Ronja Fischer, Andreas |
author_sort | Alsina-Sanchis, Elisenda |
collection | PubMed |
description | SIMPLE SUMMARY: The growth of a solid malignant tumor mass depends on the formation of new blood vessels by endothelial cells. However, endothelial cells do not only provide conduits for blood transportation, but also express numerous factors which promote the aggressiveness of cancer cells, influence the immune response toward cancer cells and thereby contribute to tumor progression and metastasis. This Review provides a comprehensive overview about such angiocrine factors and how they orchestrate the tumor microenvironment. ABSTRACT: Tumor progression, therapy resistance and metastasis are profoundly controlled by the tumor microenvironment. The contribution of endothelial cells to tumor progression was initially only attributed to the formation of new blood vessels (angiogenesis). Research in the last decade has revealed however that endothelial cells control their microenvironment through the expression of membrane-bound and secreted factors. Such angiocrine functions are frequently hijacked by cancer cells, which deregulate the signaling pathways controlling the expression of angiocrine factors. Here, we review the crosstalk between cancer cells and endothelial cells and how this contributes to the cancer stem cell phenotype, epithelial to mesenchymal transition, immunosuppression, remodeling of the extracellular matrix and intravasation of cancer cells into the bloodstream. We also address the long-distance crosstalk of a primary tumor with endothelial cells at the pre-metastatic niche and how this contributes to metastasis. |
format | Online Article Text |
id | pubmed-8198241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81982412021-06-14 Control of Tumor Progression by Angiocrine Factors Alsina-Sanchis, Elisenda Mülfarth, Ronja Fischer, Andreas Cancers (Basel) Review SIMPLE SUMMARY: The growth of a solid malignant tumor mass depends on the formation of new blood vessels by endothelial cells. However, endothelial cells do not only provide conduits for blood transportation, but also express numerous factors which promote the aggressiveness of cancer cells, influence the immune response toward cancer cells and thereby contribute to tumor progression and metastasis. This Review provides a comprehensive overview about such angiocrine factors and how they orchestrate the tumor microenvironment. ABSTRACT: Tumor progression, therapy resistance and metastasis are profoundly controlled by the tumor microenvironment. The contribution of endothelial cells to tumor progression was initially only attributed to the formation of new blood vessels (angiogenesis). Research in the last decade has revealed however that endothelial cells control their microenvironment through the expression of membrane-bound and secreted factors. Such angiocrine functions are frequently hijacked by cancer cells, which deregulate the signaling pathways controlling the expression of angiocrine factors. Here, we review the crosstalk between cancer cells and endothelial cells and how this contributes to the cancer stem cell phenotype, epithelial to mesenchymal transition, immunosuppression, remodeling of the extracellular matrix and intravasation of cancer cells into the bloodstream. We also address the long-distance crosstalk of a primary tumor with endothelial cells at the pre-metastatic niche and how this contributes to metastasis. MDPI 2021-05-26 /pmc/articles/PMC8198241/ /pubmed/34073394 http://dx.doi.org/10.3390/cancers13112610 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Alsina-Sanchis, Elisenda Mülfarth, Ronja Fischer, Andreas Control of Tumor Progression by Angiocrine Factors |
title | Control of Tumor Progression by Angiocrine Factors |
title_full | Control of Tumor Progression by Angiocrine Factors |
title_fullStr | Control of Tumor Progression by Angiocrine Factors |
title_full_unstemmed | Control of Tumor Progression by Angiocrine Factors |
title_short | Control of Tumor Progression by Angiocrine Factors |
title_sort | control of tumor progression by angiocrine factors |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198241/ https://www.ncbi.nlm.nih.gov/pubmed/34073394 http://dx.doi.org/10.3390/cancers13112610 |
work_keys_str_mv | AT alsinasanchiselisenda controloftumorprogressionbyangiocrinefactors AT mulfarthronja controloftumorprogressionbyangiocrinefactors AT fischerandreas controloftumorprogressionbyangiocrinefactors |